These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20603252)

  • 1. Migraine-like headache and status migrainosus as attacks of multiple sclerosis in a child.
    Mariotti P; Nociti V; Cianfoni A; Stefanini C; De Rose P; Martinelli D; Dittoni S; Vollono C; Batocchi AP; Della Marca G
    Pediatrics; 2010 Aug; 126(2):e459-64. PubMed ID: 20603252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of brainstem lesions with migraine-like headache: an imaging study of multiple sclerosis.
    Gee JR; Chang J; Dublin AB; Vijayan N
    Headache; 2005 Jun; 45(6):670-7. PubMed ID: 15953299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience.
    Pozzilli C; Prosperini L; Sbardella E; De Giglio L; Onesti E; Tomassini V
    Neurol Sci; 2005 Dec; 26 Suppl 4():S174-8. PubMed ID: 16388353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.
    Birnbaum G; Cree B; Altafullah I; Zinser M; Reder AT
    Neurology; 2008 Oct; 71(18):1390-5. PubMed ID: 18525027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory treatment of early onset multiple sclerosis: results of an Italian Co-operative Study.
    Ghezzi A;
    Neurol Sci; 2005 Dec; 26 Suppl 4():S183-6. PubMed ID: 16388355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interferon-beta 1a in relapsing-remitting multiple sclerosis. First report of a Mexican population].
    León C; Violante A; Arriada N; Santana HR; Corona T
    Rev Neurol; 2000 Dec 1-15; 31(11):1019-22. PubMed ID: 11190865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of remitting forms of multiple sclerosis].
    Lubetzki C
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):996-1000. PubMed ID: 11787366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relapsing-remitting inflammatory disease of the central nervous system with normal MRI: multiple sclerosis or phenocopy in a series of 15 patients].
    Lebrun C; Bourg V; Chanalet S; Chatel M
    Rev Neurol (Paris); 2003 Apr; 159(4):397-404. PubMed ID: 12773868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with interferon beta-1a and doxycycline in multiple sclerosis: an open-label trial.
    Minagar A; Alexander JS; Schwendimann RN; Kelley RE; Gonzalez-Toledo E; Jimenez JJ; Mauro L; Jy W; Smith SJ
    Arch Neurol; 2008 Feb; 65(2):199-204. PubMed ID: 18071030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Case of opticospinal multiple sclerosis showing phenotype change to conventional type induced by interferon beta-1b].
    Kanzaki M; Yomono H; Ogawa G; Motoyoshi K; Kurisaki H; Kamakura K
    Rinsho Shinkeigaku; 2007; 47(2-3):100-4. PubMed ID: 17511277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon beta-1b is effective in Japanese RRMS patients: a randomized, multicenter study.
    Saida T; Tashiro K; Itoyama Y; Sato T; Ohashi Y; Zhao Z;
    Neurology; 2005 Feb; 64(4):621-30. PubMed ID: 15728282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis.
    Gorman MP; Healy BC; Polgar-Turcsanyi M; Chitnis T
    Arch Neurol; 2009 Jan; 66(1):54-9. PubMed ID: 19139299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis in Pakistan.
    Wasay M; Ali S; Khatri IA; Hassan A; Asif M; Zakiullah N; Ahmed A; Malik A; Khealani B; Haq A; Fredrikson S
    Mult Scler; 2007 Jun; 13(5):668-9. PubMed ID: 17548448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study.
    Horakova D; Dwyer MG; Havrdova E; Cox JL; Dolezal O; Bergsland N; Rimes B; Seidl Z; Vaneckova M; Zivadinov R
    J Neurol Sci; 2009 Jul; 282(1-2):112-9. PubMed ID: 19168190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy.
    Zivadinov R; Locatelli L; Cookfair D; Srinivasaraghavan B; Bertolotto A; Ukmar M; Bratina A; Maggiore C; Bosco A; Grop A; Catalan M; Zorzon M
    Mult Scler; 2007 May; 13(4):490-501. PubMed ID: 17463072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Migraine in multiple sclerosis.
    Elliott DG
    Int Rev Neurobiol; 2007; 79():281-302. PubMed ID: 17531846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical assessment of the course of relapsing-remitting multiple sclerosis in patients treated with interferon beta].
    Pokryszko-Dragan A; Bilińska M; Gruszka E; Dubik-Jezierzańska M
    Pol Merkur Lekarski; 2005 Nov; 19(113):654-8. PubMed ID: 16498805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Retinopathy secondary to treatment with Interferon beta-1a in a patient with multiple sclerosis].
    Mallada-Frechín J; Abellán-Miralles I; Alfaro-Beltra ML; Medrano V; Muñoz-Gil MB; Fernández-Izquierdo S; Piqueras-Rodríguez L
    Rev Neurol; 2005 Apr 16-30; 40(8):482-4. PubMed ID: 15861330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical overlap of multiple sclerosis and headache.
    Applebee A
    Headache; 2012 Oct; 52 Suppl 2():111-6. PubMed ID: 23030543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.